4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-036796
Chief Accounting Officer sold 5,045 shares at $5.64 ($28,453)
From the SEC's structured data for this filing
Trades in this filing
Hagen Brett R · Chief Accounting Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-06-09 | Sale : show line 1 in the form | −5,045 | $5.64 | $28,453 | 129,512 | D |
| Open-market sales · 5,045 sh · avg $5.64 · $28,453 | ||||||
Loading xslF345X04/doc4.xml…